Cargando…
FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation
BACKGROUND: Type I pleuropulmonary blastoma (PPB) and congenital cystic adenomatoid malformation of the lung (CCAM) are cystic lung diseases of childhood. Their clinical and radiological presentations are often similar, and pathologic discrimination remains difficult in many cases. As a consequence,...
Autores principales: | Lezmi, Guillaume, Verkarre, Virginie, Khen-Dunlop, Naziha, Vibhushan, Shamila, Hadchouel, Alice, Rambaud, Caroline, Copin, Marie-Christine, Rittie, Jean-Luc, Benachi, Alexandra, Fournet, Jean-Christophe, Delacourt, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849545/ https://www.ncbi.nlm.nih.gov/pubmed/24004862 http://dx.doi.org/10.1186/1750-1172-8-130 |
Ejemplares similares
-
Congenital cystic adenomatoid malformations of the lung: an epithelial transcriptomic approach
por: Lezmi, Guillaume, et al.
Publicado: (2020) -
Deletion of Yy1 in mouse lung epithelium unveils molecular mechanisms governing pleuropulmonary blastoma pathogenesis
por: Landry-Truchon, Kim, et al.
Publicado: (2020) -
Pleuropulmonary blastoma in an adolescent
por: Bownes, Laura V., et al.
Publicado: (2020) -
Combined Effects of in Utero and Adolescent Tobacco Smoke Exposure on Lung Function in C57Bl/6J Mice
por: Drummond, David, et al.
Publicado: (2016) -
NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target
por: Shukrun, Rachel, et al.
Publicado: (2019)